Grace Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Princeton, NJ
GRCE chart
What traders are saying about $GRCE
Latest postsGrace Therapeutics, Inc. news
- Opaleye management buys $158,600 Grace Therapeutics stock By Investing.com
Investing.com Australia ·
- Form 4 Grace Therapeutics, Inc: Opaleye Management Inc. (10% Owner) For: 22 October
Investing.com Nigeria ·
- Two Opaleye, L.P. purchases in Grace Therapeutics (GRCE) cover 21,390 and 66,411 shares.
Stock Titan ·
- Grace Therapeutics, Inc. Estimates – LS:A40LEL
TradingView ·
- GRACE THERAPEUTICS INC (GRCE) Stock Chart
ChartMill ·
- Form 4 Grace Therapeutics, Inc: Opaleye Management Inc. (10% Owner) For: 19 October By Investing.com
Investing.com South Africa ·
- Opaleye Management buys $8,001 of Grace Therapeutics common stock
Investing.com ·
- At $1.88 a share, Opaleye buys 4,256 Grace Therapeutics (GRCE) shares.
Stock Titan ·
- Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference
Yahoo Finance ·
- Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update
Yahoo Finance ·
- Grace Therapeutics Announces $10 Million Private Placement
Yahoo Finance ·
- Grace Therapeutics Announces Receipt of Type A Meeting Minutes from U.S. Food and Drug Administration
Yahoo Finance ·
Grace Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$7.8M | -$9.6M | -$12.9M | -$42.4M |
| Diluted EPS | $-0.47 | $-0.79 | $-1.35 | $-5.71 |
| Total assets (year end) | $68.5M | $61.2M | $76.2M | $116.8M |
| Cash and equivalents (year end) | $18.7M | $11.1M | $18.5M | $26.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Grace Therapeutics, Inc.
- Ticker
- GRCE (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Princeton, NJ
- Incorporated in
- DE
- Fiscal year end
- March 31
- SEC CIK
- 1444192
- Former names
- Acasti Pharma Inc.
Frequently asked questions
What exchange is Grace Therapeutics, Inc. listed on?
Grace Therapeutics, Inc. trades on the Nasdaq under the ticker symbol GRCE.
What industry is Grace Therapeutics, Inc. in?
Grace Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Grace Therapeutics, Inc. headquartered?
Grace Therapeutics, Inc.'s business address on file with the SEC is in Princeton, NJ.
When does Grace Therapeutics, Inc.'s fiscal year end?
Grace Therapeutics, Inc.'s fiscal year ends on March 31.
How much revenue did Grace Therapeutics, Inc. report?
Grace Therapeutics, Inc. reported $100.0M in revenue for calendar year 2021, according to its SEC filings.